期刊文献+

经皮冠状动脉介入治疗联合血栓抽吸对ST段抬高型心肌梗死患者预后的影响 被引量:7

Effect of aspiration thrombectomy combined with primary percutaneous coronary intervention on patients with ST-segment elevation myocardial infarction
暂未订购
导出
摘要 目的评价经皮冠状动脉介入治疗(PCI)联合血栓抽吸术与单纯PCI对ST段抬高型心肌梗死(STEMI)患者预后的影响。方法选取2012年3月—2014年5月在同济大学附属第十人民医院心内科住院治疗的STEMI患者358例,随机分入血栓抽吸组和对照组,每组179例。血栓抽吸组患者于冠状动脉造影后先行血栓抽吸再行PCI,对照组患者于冠状动脉造影后直接行PCI。收集并比较两组患者术后冠状动脉血流分级\[心肌梗死溶栓治疗临床试验(TIMI)分级\],PCI术后6、12、18、24h监测的肌酸激酶同工酶(CK-MB)和心肌肌钙蛋白T(cTnT)峰值、PCI术前和术后60min心电图ST段抬高回落百分比(sumSTR)。患者出院后通过电话或门诊随访,记录术后1年有无主要不良心血管事件(MACE)发生。结果两组间术前各级TIMI血流、术中见心肌梗死相关动脉,以及病变血管构成比的差异均无统计学意义(P值均>0.05)。血栓抽吸组术后TIMI 3级、sumSTR>70%的构成比均显著高于对照组(P值均<0.01),sumSTR<30%的构成比,血浆CK-MB和cTnT峰值均显著低于对照组(P值均<0.05、0.01)。术后1年随访中,两组间未用药,以及服用阿司匹林、氯吡格雷、他汀类药物、β肾上腺素受体阻滞剂、钙通道阻滞剂、血管紧张素转换酶抑制剂、血管紧张素Ⅱ受体拮抗剂、硝酸酯类药物和利尿剂的患者构成比的差异均无统计学意义(P值均>0.05)。两组间术后1年心源性死亡、再发心肌梗死、心源性休克和纽约心脏病学会心功能分级Ⅳ级发生率的差异均无统计学意义(P值均>0.05)。结论血栓抽吸联合PCI可有效减少STEMI患者术后无复流和慢血流的发生,改善心肌再灌注,并有助于缩小心肌梗死面积。 Objective To compare the clinical outcomes between percutaneous coronary intervention (PCI) and PCI combined with thrombus aspiration in treatment of patients with ST-segment elevation myocardial infarction (STEMI). Methods A total of 358 hospitalized patients with STEMI treated in the Shanghai Tenth People's Hospital were equally divided into either thrombus aspiration group or conventional treatment group (n = 179) before coronary angiography. Thrombolysis in myocardial infarction (TIMI) flow, peak values of creatine kinase isoenzyme-MB (CK-MB) and cardiac troponin T (cTnT), and summed ST-segment resolution (sumSTR)across all infarct-related electrocardiogram (ECG) leads were recorded before and after treatment. Major adverse cardiac events (MACE), such as cardiac death, recurrent myocardial infarction, cardiogenic shock and heart failure, were recorded during one-year follow-up. Results There were no significant differences in preoperative TIMI flow, infarct-related artery or coronary lesions between the two groups (all P〉0. 05). The thrombus aspiration group had a higher rate of postoperative TIMI 3 flow and sumSTR〉70% and lower peak values of CK- MB and cTnT when compared with conventional treatment group (P〈0.01 or P〈0.05). However, no significant difference was detected between the two groups in prescribed medication or the incidence of MACE during one- year follow-up (all P〉0.05). Conclusion Compared with conventional PCI, thrombus aspiration before stent implantation in the infarct artery can significantly improve the myocardial perfusion, decrease the incidence of no- reflow and slow flow and infarct size in STEMI patients.
出处 《上海医学》 CAS CSCD 北大核心 2015年第3期179-184,共6页 Shanghai Medical Journal
基金 加拿大CANNeCTIN/CIHR基金会资助项目(TOTAL#118-SITE#801)~~
关键词 ST段抬高型心肌梗死 经皮冠状动脉介入治疗 血栓形成 血栓抽吸 Export抽吸导管 ST-segment elevation myocardial infarction Percutaneous coronary intervention Coronarythrombosis Thrombus aspiration Export thrombotic aspiration catheter
  • 相关文献

参考文献24

  • 1DEWOOD M A, SPORESJ, NOTSKE R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction[J]. N EnglJ Med , 1980, 303(16): 897-902.
  • 2DAVIES MJ, THOMAS A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death[J]. N EnglJ Med, 1984, 310(18): 1137-1140.
  • 3ZIJLSTRA F, HOORNTJEJ C, DE BOER MJ, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction[J]. N EnglJ Med , 1999,341(19): 1413-1419.
  • 4KEELEY E C, BOURAJ A, GRINES C L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials[J]. Lancet, 2003, 361( 9351): 13-20.
  • 5SILBER S, ALBERTSSON p, AVILES F F, et al. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European Society of Cardiology[J]. Eur HeartJ, 2005, 26 (8): 804-847.
  • 6STEG P G,JAMES S K, ATAR D, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation[J]. Eur HeartJ, 2012,33(20): 2569-2619.
  • 7EAGLE K A, NALLAMOTHU B K, MEHTA R H, et al. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go[J]. Eur HeartJ, 2008, 29(5): 609-617.
  • 8GIBSON C M, PRIDE Y B, FREDERICK P D, et al. Trends in reperfusion strategies, door-to-needle and door-toballoon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006[J]. Am HeartJ. 2008. 156(6): 1035-1044.
  • 9The effects of tissue plasminogen activator. streptokinase. or both on coronary-artery patency. ventricular function. and survival after acute myocardial infarction. The GUSTO Angiographic Investigators[J]. N EnglJ Med , 1993. 329 (22): 1615-1622.
  • 10STONE G W. WEBB r. COX D A. et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial[J]. lAMA. 2005. 293(9): 1063-1072.

同被引文献71

  • 1刘文兵,方快发,张亦辉,林佩环.高血糖对老年急性ST段抬高心肌梗死急诊介入治疗患者心功能及预后的影响[J].中国老年学杂志,2015,35(2):495-496. 被引量:5
  • 2Krause N,Brand R J,Arah O A,et al.Occupational physical activity and 20-year incidence of acute myocardial infarction:results from the Kuopio Ischemic Heart Disease Risk Factor Study[J].Scand J Work Environ Health,2015,41(2):124-139.
  • 3Paixao A R,Enriquez J R,Wang T Y,et al.Risk factor burden and control at the time of admission in patients with acute myocardial infarction:Results from the NCDR[J].Am Heart J,2015,170(1):173-179.
  • 4Bouleti C, Mewton N, Germain S. The no-reflow phenomenon~ State of the art[J]. Arch Cardiovasc Dis, 2015, 108(12): 661- 674.
  • 5Alak A, Jolly SS. The Role of Manual Aspiration Thrombecto- my in Patients Undergoing Primary Pereutaneous Coronary In- tervention for STEMI EJ3. Curr Cardiol Rep, 2016, 18(3) ~30.
  • 6Abdi S, Rafizadeh O, Peighambari M, et al. Evaluation of the Clinical and Procedural Predictive Factors of no-Reflow Phe- nomenon Following Primary Percutaneous Coronary Interven- tion[J~. Res Cardiovasc Med, 2015, 4(2):e25414.
  • 7Dogan NB, Ozpelit E, Akdeniz S, et al. Simple clinical risk score for no-reflow prediction in patients undergoing primary Percutaneous Coronary Intervention with acute STEMI I-J1. Pak J Med Sci, 2015, 31(3):576-581.
  • 8Zhou SS, Tian F, Chen YD, et al. Combination therapy reducesthe incidence of no-reflow after primary per-cutaneous coronary intervention in patients with ST-segment elevation acute myo- cardial infarction[J]. J Geriatr Cardiol, 2015, 12(2):135-142.
  • 9Desch S, Stiermaier T, de Waha S, et al. Thrombus Aspiration in Patients With ST-Segment Elevation Myocardial Infarction Presenting Late After Symptom Onset [J]. JACC Cardiovasc Interv, 2016, 9(2):113-122.
  • 10Shemirani H, Tafti FD, Amirpour A. Comparison of no-reflow phenomenon after percutaneous coronary intervention for acute myocardial infarction between smokers and nonsmokers [J]. J Res Med Sci, 2014, 19(11) :1068-1073.

引证文献7

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部